Home › NDC Lookup › RxCUI directory › RxCUI 753440

9 HR methylphenidate 2.22 MG/HR Transdermal System — RxCUI 753440

RxNorm drug concept · Semantic clinical drug
RxCUI 753440 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI753440
Official name9 HR methylphenidate 2.22 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethylphenidate 20 MG/9HR Transdermal System; methylphenidate 20 MG per 9HR Transdermal Patch
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)10,420 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylphenidate Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, location matters. Apply the patch to the hip area — not the waist, arm, or back. The clinical studies that established how well and how safely the patch works were done specif...
  • Where exactly do I put the patch and does it matter?
  • Water exposure — from bathing, swimming, or showering — can affect how well the patch sticks. If the patch partially or fully comes off, don't try to re-stick it with tape or adhes...
  • Can my child shower or swim while wearing the patch?
📖 Read our full Methylphenidate Transdermal Patch guide →

🕸️ Concept Web — How 9 HR methylphenidate 2.22 MG/HR Transdermal Syst... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 9 HR methylphenidate 2.22 MG/HR Transdermal System RxCUI 753440

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methylphenidate 6901
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Daytrana 631252
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylphenidate Transdermal System 1805912
    • Methylphenidate Topical Product 1163484
    • Methylphenidate Transdermal Product 1295430
    • Methylphenidate Transdermal System [Daytrana] 1805914
    • Daytrana Topical Product 1169557
    • Daytrana Transdermal Product 1296352
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methylphenidate 2.22 MG/HR SCDC · 629687
  • Methylphenidate Transdermal System SCDF · 1805912
  • Methylphenidate Topical Product SCDG · 1163484
  • Methylphenidate Transdermal Product SCDG · 1295430

Brand-Name Concepts

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 753440 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-8260-93 30 POUCH in 1 CARTON (0378-8260-93) / 1 PATCH in 1 POUCH (0... Methylphenidate Mylan Pharmaceuticals Inc. 2022-06-27
00378-8261-93 30 POUCH in 1 CARTON (0378-8261-93) / 1 PATCH in 1 POUCH (0... Methylphenidate Mylan Pharmaceuticals Inc. 2022-06-27
00378-8262-93 30 POUCH in 1 CARTON (0378-8262-93) / 1 PATCH in 1 POUCH (0... Methylphenidate Mylan Pharmaceuticals Inc. 2022-06-27
00378-8263-93 30 POUCH in 1 CARTON (0378-8263-93) / 1 PATCH in 1 POUCH (0... Methylphenidate Mylan Pharmaceuticals Inc. 2022-06-27
00574-2410-65 1 TRAY in 1 CARTON (0574-2410-65) / 30 POUCH in 1 TRAY / 1... Methylphenidate Transdermal System PADAGIS US LLC 2023-06-05
00574-2415-65 1 TRAY in 1 CARTON (0574-2415-65) / 30 POUCH in 1 TRAY / 1... Methylphenidate Transdermal System PADAGIS US LLC 2023-06-05
00574-2420-65 1 TRAY in 1 CARTON (0574-2420-65) / 30 POUCH in 1 TRAY / 1... Methylphenidate Transdermal System PADAGIS US LLC 2023-06-05
00574-2430-65 1 TRAY in 1 CARTON (0574-2430-65) / 30 POUCH in 1 TRAY / 1... Methylphenidate Transdermal System PADAGIS US LLC 2023-06-05
68968-5552-03 30 PATCH in 1 CARTON (68968-5552-3) / 9 h in 1 PATCH Daytrana Noven Therapeutics, LLC 2006-04-06
68968-5553-03 30 PATCH in 1 CARTON (68968-5553-3) / 9 h in 1 PATCH Daytrana Noven Therapeutics, LLC 2006-04-06
68968-5554-03 30 PATCH in 1 CARTON (68968-5554-3) / 9 h in 1 PATCH Daytrana Noven Therapeutics, LLC 2006-04-06
68968-5555-03 30 PATCH in 1 CARTON (68968-5555-3) / 9 h in 1 PATCH Daytrana Noven Therapeutics, LLC 2006-04-06
Observed labelers: Mylan Pharmaceuticals Inc. (4) · Noven Therapeutics, LLC (4) · PADAGIS US LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.